Atlantis Shortlisted for Three Awards at PMEA 2017

Monday, October 2, 2017

The On Path team developed a program to empower patients dealing with high cholesterol, to better self-manage their condition and positively change their outcomes.

Developed with Amgen, the personalized support program has been nominated in the following categories:

• Excellence in Patient Education and Support
• Excellence in Marketing New Products
• Excellence in Creating Value Beyond the Product

The On Path team (pictured here) developed a program to empower patients dealing with high cholesterol, to better self-manage their condition and positively change their outcomes.

Matthew Walls, Chairman and CEO of Atlantis Healthcare said: ‘This is a fantastic acknowledgement of the success of On Path. The program’s strategic and innovative approach has enabled patients to gain value beyond the drug and help realize the drug’s potential to improve patient outcomes in a highly competitive market.’ Winners of PMEA 2017 will announced on November 15, 2017 at the Sheraton Grand London Park Lane.